InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by McMeans Shaun D, Chief Financial Officer. Officer active across 1 company, notably HTG Molecular Diagnostics, INC. In total, 14 filings have been logged. History available since 10 June 2021. The latest transaction was disclosed on 9 December 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations14 total
1,000 shares@ US$0.4255.0% of flowCommon StockSEC:0001209191-22-061007:0
29 shares@ US$1.030.4% of flowCommon StockSEC:0001209191-22-040340:0
1,000 shares@ US$0.4765.8% of flowCommon StockSEC:0001209191-22-036958:0
31 shares@ US$1.390.5% of flowCommon StockSEC:0001209191-22-022376:0
31 shares@ US$5.421.8% of flowCommon StockSEC:0001209191-22-000847
31 shares@ US$5.421.9% of flowCommon StockSEC:0001209191-22-000847:0
520 shares@ US$3.561520.2% of flowCommon StockSEC:0001209191-21-069772
520 shares@ US$3.561521.2% of flowCommon StockSEC:0001209191-21-069772:0
31 shares@ US$5.712.0% of flowCommon StockSEC:0001209191-21-059009:0
31 shares@ US$5.711.9% of flowCommon StockSEC:0001209191-21-059009
31 shares@ US$5.811.9% of flowCommon StockSEC:0001209191-21-045184
31 shares@ US$5.812.0% of flowCommon StockSEC:0001209191-21-045184:0
469 shares@ US$3.918518.6% of flowCommon StockSEC:0001209191-21-040444
469 shares@ US$3.918519.6% of flowCommon StockSEC:0001209191-21-040444:0
14 of 14 declarations
About McMeans Shaun D
McMeans Shaun D serves as Chief Financial Officer and Senior Vice President of Finance & Administration at HTG Molecular Diagnostics, Inc. He oversees the company's financial management, ensuring compliance and transparency in financial operations. His expertise is crucial for supporting the company's strategy.
